| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 352 | 4.147 | 3.578 | 1.094 | 0 | 0 |
| Total Income - EUR | - | 0 | 2.221 | 129 | 1.891 | 4.878 | 4.245 | 1.901 | 24 | 11.824 |
| Total Expenses - EUR | - | 2.836 | 95.219 | 33.631 | 35.864 | 32.444 | 11.817 | 8.819 | 9.578 | 25.286 |
| Gross Profit/Loss - EUR | - | -2.836 | -92.999 | -33.501 | -33.973 | -27.567 | -7.573 | -6.918 | -9.554 | -13.462 |
| Net Profit/Loss - EUR | - | -2.836 | -93.021 | -33.503 | -33.998 | -27.730 | -7.700 | -6.994 | -9.554 | -13.462 |
| Employees | - | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Europharm Healthcare Group Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 25.869 | 11.331 | 8.344 | 378.228 | 367.006 | 398.281 | 406.982 | 414.456 | 407.883 |
| Current Assets | - | 17.204 | 11.780 | 23.534 | 125.796 | 97.249 | 48.147 | 33.714 | 15.827 | 3.175 |
| Inventories | - | 735 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 6.020 | 4.383 | 1.112 | 6.887 | 919 | 209 | 11.916 | 1.469 | 2.501 |
| Cash | - | 10.449 | 7.397 | 22.422 | 118.908 | 96.330 | 47.938 | 21.798 | 14.358 | 673 |
| Shareholders Funds | - | -2.792 | -95.591 | -127.339 | -158.871 | -183.589 | -187.218 | -194.793 | -203.756 | -216.079 |
| Social Capital | - | 45 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | 45.865 | 118.702 | 159.217 | 662.895 | 648.937 | 634.499 | 636.702 | 634.581 | 627.676 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2110 - 2110" | |||||||||
| CAEN Financial Year |
2110
|
|||||||||
Comments - Europharm Healthcare Group Srl